Mobile

A Six-Week/Six-Week, Prospective, Randomised, Masked, Cross over, Primary Therapy Study comparing IOP Lowering Effects of Lumigan® and Xalatan® in Subjects with Primary Open Angle Glaucoma, Ocular Hy...

Mise à jour : Il y a 4 ans
Référence : EUCTR2004-002979-16

A Six-Week/Six-Week, Prospective, Randomised, Masked, Cross over, Primary Therapy Study comparing IOP Lowering Effects of Lumigan® and Xalatan® in Subjects with Primary Open Angle Glaucoma, Ocular Hypertension, Pseudoexfoliation glaucoma & Pigment dispersion

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To measure the relative efficacy in lowering of intraocular pressure of Bimatoprost vs Latanoprost in subjects suffering from Primary Open Angle Glaucoma, Ocular Hypertension, Pseudoexfoliation glaucoma & Pigment dispersion.

Critère d'inclusion

  • Primary open-angle glaucoma, Ocular hypertension, Pseudoexfoliation glaucoma or Pigment dispersion

Liens